DDB1

DDB1 Full Name

damage-specific DNA binding protein 1, 128kDa

DDB1 Introduction

DDB1 (Damage-Specific DNA Binding Protein 1, 128 kDa) is a highly conserved multifunctional protein that occupies a central position at the intersection of DNA damage recognition, ubiquitin-mediated protein degradation, chromatin regulation, and genome stability. For researchers investigating cancer biology, DNA repair pathways, or targeted protein degradation, understanding DDB1 is essential because alterations in this adaptor protein can influence numerous cellular processes rather than a single signaling pathway. Initially identified as a component of the UV-damaged DNA binding complex involved in nucleotide excision repair, DDB1 is now recognized as the core adaptor of the Cullin 4-RING E3 ubiquitin ligase (CRL4) complex, where it bridges CUL4A/CUL4B scaffold proteins with a diverse family of DDB1- and CUL4-associated factors (DCAFs). Through this architecture, DDB1 enables selective recruitment of dozens of substrate receptors, allowing CRL4 complexes to regulate hundreds of proteins involved in DNA replication, transcription, epigenetic remodeling, cell-cycle progression, and stress responses. Recent studies further demonstrate that DDB1 functions as an evolutionarily conserved chromatin regulator whose activity is tightly controlled by NEDD8 modification of CUL4 proteins, highlighting its fundamental role in maintaining cellular homeostasis across normal development and disease.

Beyond serving as a structural adaptor, DDB1 functions as a master coordinator of protein quality control during genome maintenance. By assembling substrate-specific CRL4 ubiquitin ligase complexes, DDB1 promotes ubiquitination and controlled degradation of proteins that must be rapidly removed following DNA damage or during normal cell-cycle progression. Emerging evidence has expanded its biological significance far beyond classical nucleotide excision repair. DDB1-containing CRL4 complexes regulate transcription-coupled DNA repair by controlling the turnover of RNA polymerase II-associated repair factors, ensuring efficient recovery of transcription after UV-induced damage. Additional studies have shown that DDB1 interacts with components of the DNA damage checkpoint machinery, including NBS1, contributing to checkpoint recovery following double-strand breaks and replication stress while preventing prolonged CHK1 activation. DDB1 also participates in epigenetic regulation through substrate-specific DCAF proteins, such as DCAF13-mediated degradation of MeCP2, thereby preventing excessive DNA methylation and maintaining appropriate gene expression during oocyte development. Collectively, these findings position DDB1 as a central molecular hub integrating DNA repair, chromatin remodeling, ubiquitin signaling, replication fidelity, and transcriptional regulation, making it one of the most broadly connected regulatory proteins in the DNA damage response network.

Growing evidence links DDB1 dysregulation to numerous human diseases, making it an increasingly attractive therapeutic and biomarker target. Because DDB1 controls the stability of many oncogenic and tumor-suppressive proteins through CRL4 ubiquitin ligases, abnormal DDB1 activity has been implicated in multiple malignancies, including liver, lung, colorectal, breast, ovarian, and hematologic cancers, where altered protein turnover contributes to uncontrolled proliferation, genomic instability, therapeutic resistance, and metastatic progression. Inherited or acquired defects affecting DDB1-dependent DNA repair mechanisms may also increase susceptibility to DNA damage accumulation and chromosomal instability. Beyond oncology, recent research demonstrates that loss of DDB1 in oocytes leads to premature ovarian failure through disruption of epigenetic homeostasis, underscoring its essential role in reproductive biology and early embryonic development. DDB1 is additionally involved in cellular responses to viral infection, replication stress, and chromatin-associated diseases, while many viruses exploit DDB1-containing CRL4 complexes to promote degradation of host antiviral proteins. As targeted protein degradation technologies, molecular glues, and PROTAC-based therapeutics continue to advance, DDB1 has emerged as a strategically important component of ubiquitin signaling that offers new opportunities for developing precision therapies aimed at restoring protein homeostasis, improving DNA repair regulation, and selectively eliminating disease-driving proteins.

Alternate Names for DDB1

damage-specific DNA binding protein 1, 127kDa;UV-DDB 1;XPE;XPE-binding factor;Damage-specific DNA-binding protein 1;damage-specific DNA binding protein 1 (127kD);Xeroderma pigmentosum group E-complementing protein;DDBA;XAP-1;XAP1;XPE-BF;UV-DDB1;DDB p127 subunit;XPCE;DNA damage-binding protein a;DNA damage-binding protein 1;HBV X-associated protein 1;DDBa;UV-damaged DNA-binding factor;XPCe;UV-damaged DNA-binding protein 1;DDB1_HUMAN;

• 1.Nakagawa M, Nakagawa T. CUL4-Based Ubiquitin Ligases in Chromatin Regulation: An Evolutionary Perspective. Cells. 2025, 14(2):63.
  2.Ren P, et al.; CRL4DCAF13 E3 ubiquitin ligase targets MeCP2 for degradation to prevent DNA hypermethylation and ensure normal transcription in growing oocytes. Cell Mol Life Sci. 2024, 81(1):165.